The U.S. Department of Health and Human Services announced it will decertify Network for Hope, a Kentucky-based organ procurement organization, following allegations that staff continued with organ retrieval procedures despite patients showing signs of life, including a case where a patient was thrashing, crying, and shaking his head.
Becton Dickinson is recalling certain lots of intraosseous vascular access system needle sets following reports of four deaths and multiple injuries. The FDA issued an early alert warning that needle components may lock during insertion, potentially delaying critical care.
Poison control centers have experienced a sharp increase in calls related to semaglutide medications (Ozempic and Wegovy) following their approval for weight management, with researchers finding most cases stem from preventable dosing mistakes such as daily instead of weekly injections or confusion about proper dosage units.
The Philadelphia Department of Public Health recommended patients at a Rittenhouse Square dental office get tested for Hepatitis B, Hepatitis C, and HIV after the office's license was suspended due to infection control violations.
The U.S. Food and Drug Administration has rejected a proposal to reduce regulatory oversight of AI-powered medical devices, highlighting growing policy tension between promoting innovation and ensuring patient safety as AI adoption accelerates in healthcare.
A landmark trial presented at ESCMID Global 2026 demonstrates that improving oral hygiene for hospital patients can reduce the risk of non-ventilator-associated hospital-acquired pneumonia by 60%, offering a simple intervention to prevent a serious complication.
